Search all trials

Find therapies in clinical trials near you – page 43

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 961
countries: 28
conditions: 2 103

3 961 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Non-small cell lung cancer+1

Not recruiting

InvestigationalNo placebo

Study on the Effectiveness and Safety of UV1 Vaccine with or without Sargramostim for Patients with Advanced or Metastatic Non-Small Cell Lung Cancer

InvestigationalNo placebo

Norway

Participants:18–64 years · 65+ years
Substances:Alrefimotide

Contact Research Centre

Endometrial cancer

Not recruiting

Registered drug

Study of Pembrolizumab with Chemotherapy for High-Risk Endometrial Cancer Patients After Surgery

Registered drug

Norway

Participants:18–64 years · 65+ years
Substances:Anhydrous Docetaxel

Contact Research Centre

Gastrointestinal stromal tumour

Not recruiting

Registered drugNo placebo

Study of Ripretinib vs Sunitinib for Patients with Advanced Gastrointestinal Stromal Tumor with Specific KIT Exon Mutations Previously Treated with Imatinib

Registered drugNo placebo

Norway

Participants:18–64 years · 65+ years
Substances:Ripretinib

Contact Research Centre

Renal cell carcinoma

Not recruiting

Registered drugNo placebo

Study of Pembrolizumab, Belzutifan, and Lenvatinib for Patients with Advanced Clear Cell Renal Cell Carcinoma

Registered drugNo placebo

Norway

Participants:18–64 years · 65+ years
Substances:Belzutifan

Contact Research Centre

Non-small cell lung cancer

Not recruiting

Registered drug

Study of Belrestotug and Dostarlimab for Patients with Untreated Advanced Non-Small Cell Lung Cancer

Registered drug

Norway

Participants:18–64 years · 65+ years
Substances:Dostarlimab

Contact Research Centre

Non-small cell lung cancer

Not recruiting

Registered drugNo placebo

Study Comparing Patritumab Deruxtecan and Platinum-based Chemotherapy for Patients with Advanced EGFR-mutated Non-small Cell Lung Cancer After EGFR Therapy Failure

Registered drugNo placebo

Norway

Participants:18–64 years · 65+ years
Substances:Carboplatin

Contact Research Centre

Study on Langerhans Cell Histiocytosis Treatment in Children and Adolescents Using Cladribine, Prednisolone, and Cytarabine

Not recruiting

Registered drugNo placebo

Study on Langerhans Cell Histiocytosis Treatment in Children and Adolescents Using Cladribine, Prednisolone, and Cytarabine

Registered drugNo placebo

Norway

Participants:0–17 years
Substances:Alemtuzumab

Contact Research Centre

Plasma cell myeloma

Not recruiting

Registered drugNo placebo

Study on Isatuximab, Bortezomib, and Lenalidomide for Patients with Newly Diagnosed Multiple Myeloma Not Eligible for Transplant

Registered drugNo placebo

Norway

Participants:65+ years
Substances:Bortezomib

Contact Research Centre

Labour induction

Not recruiting

Registered drug

Study on the Effectiveness of Oral Sodium Bicarbonate and Intravenous Hyoscine Butylbromide for Facilitating Natural Childbirth in Pregnant Women Induced for Labor

Registered drug

Norway

Participants:18–64 years
Substances:Sodium Chloride

Contact Research Centre

Small cell lung cancer

Not recruiting

Registered drugNo placebo

Study on Atezolizumab with Chemoradiotherapy for Patients with Limited Disease Small-Cell Lung Cancer

Registered drugNo placebo

Norway

Participants:18–64 years · 65+ years
Substances:Atezolizumab

Contact Research Centre

Systemic mastocytosis+1

Not recruiting

Investigational

Study of Avapritinib for Patients with Indolent Systemic Mastocytosis Not Adequately Managed by Standard Therapy

Investigational

Norway

Participants:18–64 years · 65+ years
Substances:Avapritinib

Contact Research Centre

Plasma cell myeloma refractory

Not recruiting

InvestigationalNo placebo

Study of isatuximab and pegenzileukin combination treatment for patients with relapsed or refractory multiple myeloma who previously received anti-CD38 and anti-BCMA therapy

InvestigationalNo placebo

Norway

Participants:18–64 years · 65+ years
Substances:Isatuximab

Contact Research Centre

Find therapies in clinical trials near you – page 43

527 trials match your criteria

Non-small cell lung cancer+1

Study on the Effectiveness and Safety of UV1 Vaccine with or without Sargramostim for Patients with Advanced or Metastatic Non-Small Cell Lung Cancer

Endometrial cancer

Study of Pembrolizumab with Chemotherapy for High-Risk Endometrial Cancer Patients After Surgery

Gastrointestinal stromal tumour

Study of Ripretinib vs Sunitinib for Patients with Advanced Gastrointestinal Stromal Tumor with Specific KIT Exon Mutations Previously Treated with Imatinib

Renal cell carcinoma

Study of Pembrolizumab, Belzutifan, and Lenvatinib for Patients with Advanced Clear Cell Renal Cell Carcinoma

Non-small cell lung cancer

Study of Belrestotug and Dostarlimab for Patients with Untreated Advanced Non-Small Cell Lung Cancer

Non-small cell lung cancer

Study Comparing Patritumab Deruxtecan and Platinum-based Chemotherapy for Patients with Advanced EGFR-mutated Non-small Cell Lung Cancer After EGFR Therapy Failure

Study on Langerhans Cell Histiocytosis Treatment in Children and Adolescents Using Cladribine, Prednisolone, and Cytarabine

Study on Langerhans Cell Histiocytosis Treatment in Children and Adolescents Using Cladribine, Prednisolone, and Cytarabine

Plasma cell myeloma

Study on Isatuximab, Bortezomib, and Lenalidomide for Patients with Newly Diagnosed Multiple Myeloma Not Eligible for Transplant

Labour induction

Study on the Effectiveness of Oral Sodium Bicarbonate and Intravenous Hyoscine Butylbromide for Facilitating Natural Childbirth in Pregnant Women Induced for Labor

Small cell lung cancer

Study on Atezolizumab with Chemoradiotherapy for Patients with Limited Disease Small-Cell Lung Cancer

Systemic mastocytosis+1

Study of Avapritinib for Patients with Indolent Systemic Mastocytosis Not Adequately Managed by Standard Therapy

Plasma cell myeloma refractory

Study of isatuximab and pegenzileukin combination treatment for patients with relapsed or refractory multiple myeloma who previously received anti-CD38 and anti-BCMA therapy

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.